COVID-19 Convalescent Plasma Therapy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

August 10, 2020

Primary Completion Date

December 10, 2020

Study Completion Date

January 10, 2021

Conditions
SARS-CoV-2 InfectionCOVID-19 Infection
Interventions
BIOLOGICAL

Convalescent plasma

COVID-19 convalescent plasma at admission, after confirmation of eligibility, 200 ml on day 1 and 2

Trial Locations (1)

111421

Facultad de Ciencias Médicas - Universidad Nacional de Asunción, Asunción

All Listed Sponsors
collaborator

Consejo Nacional de Ciencias y Tecnología, Paraguay

UNKNOWN

collaborator

Ministerio de Salud Pública y Bienestar Social, Paraguay

UNKNOWN

collaborator

Centro de información y recursos para el desarrollo, Paraguay

UNKNOWN

lead

Universidad Nacional de Asunción

OTHER

NCT04747158 - COVID-19 Convalescent Plasma Therapy | Biotech Hunter | Biotech Hunter